|
|
response to growth factor
|
GO:0070848 |
198 |
0.568
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.484
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.400
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.379
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.356
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.342
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.320
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.312
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.308
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.288
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.279
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.273
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.269
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.262
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.254
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.226
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.218
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.216
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.214
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.208
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.201
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.201
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.198
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.195
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.191
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.186
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.184
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.182
|
Human |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.181
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.175
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.175
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.166
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.163
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.162
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.158
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.155
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.151
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.151
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.150
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.148
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.148
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.142
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.138
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.138
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.132
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.132
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.130
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.126
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.125
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.124
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.123
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.123
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.122
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.121
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.120
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.119
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.118
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.113
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.112
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.111
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.108
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.107
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.107
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.106
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.105
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.104
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.102
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.101
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.101
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.100
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.100
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.100
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.095
|
Human |
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.095
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.094
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.093
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.093
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.092
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.092
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.092
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.091
|
Human |
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.090
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.090
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.089
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.089
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.088
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.087
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.087
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.087
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.086
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.086
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.085
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.083
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.083
|
Human |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.080
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.080
|
|
|
|
rap protein signal transduction
|
GO:0032486 |
3 |
0.079
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.079
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.078
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.077
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.076
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.076
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.074
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.074
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.073
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.073
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.073
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.072
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.071
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.070
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.070
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.069
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.069
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.069
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.067
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.067
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.066
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.066
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.065
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.065
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.064
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.062
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.062
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.060
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.060
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.059
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.058
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.058
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.058
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.058
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.057
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.057
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.056
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.056
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.055
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.055
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.054
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.054
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.054
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.054
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.053
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.053
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.053
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.053
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.053
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.053
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.052
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.052
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.052
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.052
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.052
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.051
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.051
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.051
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.051
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.051
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.050
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.050
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.050
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.049
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.049
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.049
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.048
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.048
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.047
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.047
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.047
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.047
|
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.047
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.047
|
|
|
|
cellular response to amino acid stimulus
|
GO:0071230 |
29 |
0.047
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.046
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.046
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.046
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.046
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.045
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.045
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.045
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.044
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.044
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.044
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.044
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.044
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.044
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.044
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.044
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.044
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.043
|
|
|
|
rhodopsin mediated signaling pathway
|
GO:0016056 |
4 |
0.043
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.043
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.043
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.043
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.043
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.042
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.042
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.042
|
|
|
|
cyclic nucleotide metabolic process
|
GO:0009187 |
59 |
0.042
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.042
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.042
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.041
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.041
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.041
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.041
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.041
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.040
|
|
|
|
ventral trunk neural crest cell migration
|
GO:0036486 |
4 |
0.040
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.040
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.040
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.040
|
Human |
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.040
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.039
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.039
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.039
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.039
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.039
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.039
|
|
|
|
negative regulation of phospholipase activity
|
GO:0010519 |
4 |
0.039
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.038
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.038
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.038
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.038
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.038
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.038
|
Human |
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.038
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.037
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.037
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.037
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.037
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.037
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.037
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.037
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.037
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.037
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.037
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.036
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.036
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.036
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.036
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.036
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.036
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.036
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.035
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.035
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.035
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.035
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.035
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.035
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.035
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.034
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.034
|
|
|
|
regulation of cyclic nucleotide biosynthetic process
|
GO:0030802 |
31 |
0.034
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.034
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.034
|
|
|
|
smooth muscle cell chemotaxis
|
GO:0071670 |
2 |
0.034
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.034
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.034
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.034
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.033
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.033
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.033
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.033
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.033
|
|
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.033
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.033
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.033
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.033
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.032
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.032
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.032
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.032
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.032
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.032
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.032
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.032
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.031
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.031
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.031
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.031
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.031
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.031
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.031
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.031
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.031
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.031
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.030
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.030
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.030
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.030
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.030
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.030
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.030
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.030
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.029
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.029
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.029
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.029
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.029
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.029
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.029
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.029
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.029
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.029
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.029
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.028
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.028
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.028
|
Human |
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.027
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.027
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.027
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.027
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.027
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.027
|
Human |
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.027
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.026
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.026
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.026
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.026
|
|
|
|
detection of external stimulus
|
GO:0009581 |
61 |
0.026
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.026
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.026
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.026
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.026
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.026
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.026
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.026
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.025
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.025
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.025
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.025
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.025
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.025
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.025
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.025
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.025
|
|
|
|
relaxation of smooth muscle
|
GO:0044557 |
8 |
0.025
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.025
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.025
|
|
|
|
striated muscle contraction
|
GO:0006941 |
45 |
0.025
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.025
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.025
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.024
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.024
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.024
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.024
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.024
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.024
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.024
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.024
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.024
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.024
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.024
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.024
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.024
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.024
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.024
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.023
|
|
|
|
substrate dependent cerebral cortex tangential migration
|
GO:0021825 |
3 |
0.023
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.023
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.023
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.023
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.023
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.023
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.023
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.023
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.023
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.023
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.023
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.023
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.023
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.023
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.022
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.022
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.022
|
|
|
|
camp metabolic process
|
GO:0046058 |
40 |
0.022
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.022
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.022
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.022
|
|
|
|
cyclic purine nucleotide metabolic process
|
GO:0052652 |
43 |
0.022
|
|
|
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.022
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.022
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.022
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.022
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.022
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.022
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.022
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.022
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.022
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.022
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.022
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.022
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.022
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.021
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.021
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.021
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.021
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.021
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.021
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.021
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.021
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.021
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
13 |
0.021
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.021
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.021
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.021
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.021
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.021
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.021
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.021
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.021
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.021
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.021
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.021
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.020
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.020
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.020
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.020
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.020
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.020
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.020
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.020
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.020
|
|
|
|
inter male aggressive behavior
|
GO:0002121 |
3 |
0.020
|
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.020
|
|
|
|
relaxation of vascular smooth muscle
|
GO:0060087 |
7 |
0.020
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.020
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.020
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.020
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.020
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.020
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.020
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.019
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.019
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.019
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.019
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.019
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.019
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.019
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
78 |
0.019
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.019
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.019
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.019
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.019
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.019
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.019
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.019
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.019
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.019
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.019
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.019
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.019
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.019
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.019
|
|
|
|
substrate adhesion dependent cell spreading
|
GO:0034446 |
30 |
0.019
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.019
|
|
|
|
establishment of glial blood brain barrier
|
GO:0060857 |
2 |
0.019
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.019
|
|
|
|
positive regulation of metanephric mesenchymal cell migration
|
GO:2000591 |
1 |
0.019
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.019
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.019
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.019
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.018
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.018
|
|
|
|
regulation of purine nucleotide biosynthetic process
|
GO:1900371 |
34 |
0.018
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.018
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.018
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.018
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.018
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.018
|
|
|
|
positive regulation of purine nucleotide biosynthetic process
|
GO:1900373 |
26 |
0.018
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.018
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.018
|
|
|
|
axon target recognition
|
GO:0007412 |
4 |
0.018
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.018
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.018
|
|
|
|
relaxation of muscle
|
GO:0090075 |
18 |
0.018
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.018
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.018
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.018
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.018
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.018
|
|
|
|
mechanoreceptor differentiation
|
GO:0042490 |
67 |
0.018
|
|
|
|
dendritic spine maintenance
|
GO:0097062 |
4 |
0.018
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.018
|
|
